US · guidance
CMS Pub. 100-18, ch. 6, § 30.1.6
Formulary Exceptions
P&T committees must review for clinical appropriateness protocols and procedures for the
timely use of and access to both formulary and non-formulary drug products. Part D coverage
determinations and appeals information can be found in chapter 18 of this manual.
History
(Rev. 2, Issued: 07-18-08; Effective/Implementation Date: 07-18-08)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- iom-2026-09-17
- Content hash
251a9b306a6e868722fe6bdc2eec71dbaae8e72e092bafd054bb4c6d2efce7dc
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.